Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gibril Ndow

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
JHEP Reports : Innovation in Hepatology|September 9, 2020
Hepatitis B virus preS2Δ38-55 variants: A newly identified risk factor for hepatocellular carcinomaDamien Cohen, Sumantra Ghosh, Yusuke Shimakawa, et al.
The Journal of Infectious Diseases|April 30, 2025
Residual risk of hepatitis B virus (HBV) mother-to-child transmission and gaps in HBV care cascades among pregnant women in The Gambia: the INFANT-B studyGibril Ndow, Rohey Bangura, Erwan Vo-Quang, et al.
Journal of Hepatology|August 15, 2018
Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in AfricaYusuke Shimakawa, Ramou Njie, Gibril Ndow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 12, 2026
Field performance and acceptability of the hepatitis B core-related antigen rapid diagnostic test (HBcrAg-RDT) for detecting high viral load among pregnant women in The Gambia (PROTECT-B)Alexandra M Famiglietti, Sainabou Drammeh, Erwan Vo-Quang, et al.
The Lancet. Gastroenterology & Hepatology|July 10, 2022
Hepatocellular carcinoma: measures to improve the outlook in sub-Saharan AfricaC Wendy Spearman, Geoffrey Dusheiko, Eduard Jonas, et al.
The Lancet. Gastroenterology & Hepatology|November 9, 2024
Clinical outcomes of untreated adults living with chronic hepatitis B in The Gambia: an analysis of data from the prospective PROLIFICA cohort studyGibril Ndow, Yusuke Shimakawa, Damien Leith, et al.
BMC Medicine|July 4, 2023
Informing a target product profile for rapid tests to identify HBV-infected pregnant women with high viral loads: a discrete choice experiment with African healthcare workersYasir Shitu Isa, Jonathan Sicsic, Henry Njuguna, et al.
The Lancet. Gastroenterology & Hepatology|February 17, 2024
Development and evaluation of a simple treatment eligibility score (HEPSANET) to decentralise hepatitis B care in Africa: a cross-sectional studyNicolas Minier, Alice Nanelin Guingané, Edith Okeke, et al.
The Lancet. Global Health|July 23, 2016
Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) studyMaud Lemoine, Yusuke Shimakawa, Ramou Njie, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
JHEP Reports : Innovation in Hepatology|September 9, 2020
Hepatitis B virus preS2Δ38-55 variants: A newly identified risk factor for hepatocellular carcinomaDamien Cohen, Sumantra Ghosh, Yusuke Shimakawa, et al.
The Journal of Infectious Diseases|April 30, 2025
Residual risk of hepatitis B virus (HBV) mother-to-child transmission and gaps in HBV care cascades among pregnant women in The Gambia: the INFANT-B studyGibril Ndow, Rohey Bangura, Erwan Vo-Quang, et al.
Journal of Hepatology|August 15, 2018
Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in AfricaYusuke Shimakawa, Ramou Njie, Gibril Ndow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 12, 2026
Field performance and acceptability of the hepatitis B core-related antigen rapid diagnostic test (HBcrAg-RDT) for detecting high viral load among pregnant women in The Gambia (PROTECT-B)Alexandra M Famiglietti, Sainabou Drammeh, Erwan Vo-Quang, et al.
The Lancet. Gastroenterology & Hepatology|July 10, 2022
Hepatocellular carcinoma: measures to improve the outlook in sub-Saharan AfricaC Wendy Spearman, Geoffrey Dusheiko, Eduard Jonas, et al.
The Lancet. Gastroenterology & Hepatology|November 9, 2024
Clinical outcomes of untreated adults living with chronic hepatitis B in The Gambia: an analysis of data from the prospective PROLIFICA cohort studyGibril Ndow, Yusuke Shimakawa, Damien Leith, et al.
BMC Medicine|July 4, 2023
Informing a target product profile for rapid tests to identify HBV-infected pregnant women with high viral loads: a discrete choice experiment with African healthcare workersYasir Shitu Isa, Jonathan Sicsic, Henry Njuguna, et al.
The Lancet. Gastroenterology & Hepatology|February 17, 2024
Development and evaluation of a simple treatment eligibility score (HEPSANET) to decentralise hepatitis B care in Africa: a cross-sectional studyNicolas Minier, Alice Nanelin Guingané, Edith Okeke, et al.
The Lancet. Global Health|July 23, 2016
Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) studyMaud Lemoine, Yusuke Shimakawa, Ramou Njie, et al.
Pageof 5